Escola Paulista de Medicina
Postgraduate in Clinical Endocrinology

Use of a Sodium-Glucose Cotransporter 2 Inhibitor, Empagliflozin, in a Patient with Rabson-Mendenhall Syndrome

224036

Artigos Relacionados - Artigos Científicos

31 Mar 2017 20:05


Objective: 
As Selumetinib is a MEK1/2 inhibitor that has gained interest as an anti-tumor agent, [ ... ]

Artigos Cientificos

© 2013 - 2019 Universidade Federal de São Paulo - Unifesp

Rua  Estado de Israel, 639 - Vila Clementino - São Paulo/SP - 04022-001 • 5089-9200 Ramal 2416